Diabetes in People with HIV
- PMID: 33730223
- PMCID: PMC8208107
- DOI: 10.1007/s11892-021-01382-8
Diabetes in People with HIV
Abstract
Purpose of review: To discuss the diagnosis, treatment, and complications of diabetes in people with HIV (PWH) and to review HIV-related factors that may contribute to the development of diabetes or alter decisions in the care and treatment of PWH with diabetes.
Recent findings: For those patients with atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease, GLP-1 receptor agonists and SGLT-2 inhibitors should be considered for use. Evidence for this recommendation is, however, based on studies that were not conducted in populations consisting solely of PWH. Diabetes is a significant comorbidity in PWH and adds to their already heightened risk of cardiovascular disease. HIV-specific factors, including interactions of antiretroviral therapy with medications that either treat diabetes and/or prevent cardiovascular disease, should be evaluated.
Keywords: Antiretroviral therapy; Diabetes; HIV; Macrovascular complications; Microvascular complications.
References
-
- Buchacz K, Baker RK, Palella FJ, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18(1):65–75. - PubMed
-
- Warriner AH, Burkholder GA, Overton ET. HIV-Related Metabolic Comorbidities in the Current ART Era. Infect Dis Clin N Am. 2014;28(3):457–+. - PubMed
-
- Noubissi EC, Katte JC, Sobngwi E. Diabetes and HIV. Curr Diabetes Rep. 2018;18(11). - PubMed
-
- Brown TT, Cole SR, Li XH, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med. 2005;165(10):1179–1184. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
